0000899243-16-013575.txt : 20160217 0000899243-16-013575.hdr.sgml : 20160217 20160217174926 ACCESSION NUMBER: 0000899243-16-013575 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160214 FILED AS OF DATE: 20160217 DATE AS OF CHANGE: 20160217 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Williams Michael J PhD CENTRAL INDEX KEY: 0001377232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 161435297 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 FORMER NAME: FORMER CONFORMED NAME: Williams Michael J DATE OF NAME CHANGE: 20061003 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001377232 Williams Michael J PhD ONE IDEXX DRIVE WESTBROOK ME 04092 1 1 0 0 Executive Vice President Common Stock 2016-02-14 4 M 0 514 0.00 A 40856 D Common Stock 2016-02-14 4 M 0 514 0.00 A 41370 D Common Stock 2016-02-14 4 M 0 545 0.00 A 41915 D Common Stock 2016-02-14 4 M 0 403 0.00 A 42318 D Common Stock 2016-02-14 4 M 0 472 0.00 A 42790 D Common Stock 2016-02-14 4 F 0 779 67.85 D 42011 D Non-Qualified Stock Option (right-to-buy) 67.85 2016-02-14 4 A 0 13424 A 2026-02-13 Common Stock 13424 13424 D Incentive Stock Option (right-to-buy) 67.85 2016-02-14 4 A 0 1476 A 2026-02-13 Common Stock 1476 1476 D Restricted Stock Unit 2016-02-14 4 A 0 3685 A 2026-02-13 Common Stock 3685 16313 D Restricted Stock Unit 2016-02-14 4 M 0 514 D Common Stock 514 15799 D Restricted Stock Unit 2016-02-14 4 M 0 514 D Common Stock 514 15285 D Restricted Stock Unit 2016-02-14 4 M 0 545 D Common Stock 545 14740 D Restricted Stock Unit 2016-02-14 4 M 0 403 D Common Stock 403 14337 D Restricted Stock Unit 2016-02-14 4 M 0 472 D Common Stock 472 13865 D Includes 84 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on December 31, 2015. Closing price of Issuer's common stock on the NASDAQ market on February 12, 2016. Grant of option to buy shares of Issuer common stock that becomes exercisable in five annual installments beginning February 14, 2017. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2017. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five equal annual installments, beginning February 14, 2012 and has been adjusted to reflect the the 2-for-1 stock split of Issuer common stock that occurred on June 15, 2015 (the "Stock Split"). Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2013 and has been adjusted to reflect the Stock Split. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2014 and has been adjusted to reflect the Stock Split. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2015 and has been adjusted to reflect the Stock Split. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five equal annual installments, beginning February 14, 2016 and has been adjusted to reflect the Stock Split. Not applicable. /s/ Jacqueline L. Studer, Attorney-in-Fact for Michael J. Williams, PhD 2016-02-17